Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Customer Support
Subscribe
Reports
Agribusiness Consulting
Advertise
UsernamePublicRestriction
Tags:
R&D Pharmaceuticals Vaccines

Panel of experts discuss animal health innovation in exclusive Animal Pharm video

  • Analysis

At the recent Animal Health Investment Europe forum in London, Animal Pharm editor Joseph Harvey quizzed a panel of experts on the future of industry innovation. Below is a video of the full panel discussion featuring Boehringer Ingelheim Animal Health, Antelliq and ViroVet.

From left to right on the panel are: Joseph Harvey (editor, Animal Pharm); Stefan Weiskopf (chief executive of Antelliq); Randolph Seidler (vice president and global head of business development at Boehringer Ingelheim Animal Health); and Erwin Blomsma (chief executive of ViroVet).

The panel looked at animal health innovation from the viewpoint of a multinational, a data-focused company and a start-up.

Open Media

Table

View full table

Topics

What to read next

Tags:
R&D Pharmaceuticals Vaccines
UsernamePublicRestriction

Register

AP002434

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By